Literature DB >> 3595078

Circadian variation of thyrotrophin, determined by ultrasensitive immunoradiometric assay, and the effect of low dose nocturnal dopamine infusion.

D J Kerr, V K Singh, M G McConway, G H Beastall, J M Connell, W D Alexander, D L Davies.   

Abstract

The effect of low dose dopamine infusion on the circadian rhythm of thyrotrophin (TSH), prolactin and cortisol in a group of six healthy male volunteers is reported. Subjects were infused in random order with either saline (154 mmol/l NaCl solution; control) or dopamine (0.1 and 1 microgram min-1 kg-1) between 21.00 and 01.00 hours, in random order. The serum TSH profile was characterized by a maximal peak occurring at 23.00 hours and higher nocturnal than diurnal values. Superimposed on this are short term oscillations in serum TSH levels, typical of an ultradian rhythm. The maximal peak in TSH, occurring at 23.00 hours, was abolished by dopamine infused at a rate of 1 microgram min-1 kg-1, and was unaffected by the lower rate of dopamine infusion (0.1 microgram min-1 kg-1). The serum prolactin profile was characterized by a peak occurring soon after the onset of sleep (23.30-00.30 hours), which fell during the morning, and began to rise in late evening. Low dose dopamine (0.1 microgram min-1 kg-1) had a slight but insignificant effect with decreased prolactin levels at the end of the infusion whereas the higher dopamine dose was associated with significantly lower prolactin levels during and throughout the infusion. There was a rebound to levels significantly higher than control on cessation of the infusion. Cortisol levels were unaffected by dopamine.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3595078     DOI: 10.1042/cs0720737

Source DB:  PubMed          Journal:  Clin Sci (Lond)        ISSN: 0143-5221            Impact factor:   6.124


  4 in total

1.  The pharmacokinetics and pharmacodynamics of lisuride in healthy volunteers after intravenous, intramuscular, and subcutaneous injection.

Authors:  W Krause; T Mager; G Kühne; T Duka; B Voet
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Significance of latent hyperthyroidism.

Authors:  I Vardarli; I Vardarli; R Schmidt; R Paschke; L Schaaf; B Scholte-Sautter; J Teuber; U Feldmann; K H Usadel
Journal:  Klin Wochenschr       Date:  1989-05-15

3.  Lack of effect of the dopamine D1 antagonist, NNC 01-0687, on unstimulated and stimulated release of anterior pituitary hormones in males.

Authors:  E Grodum; M Andersen; J Hangaard; O Koldkjaer; C Hagen
Journal:  J Endocrinol Invest       Date:  1998-05       Impact factor: 4.256

Review 4.  A Review of the Pharmacokinetics of Levothyroxine for the Treatment of Hypothyroidism.

Authors:  Philippe Colucci; Corinne Seng Yue; Murray Ducharme; Salvatore Benvenga
Journal:  Eur Endocrinol       Date:  2013-03-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.